Published: Jun 7, 2026
Written by Klarity Editorial Team
Published: Jun 7, 2026

If you’re struggling with Binge Eating Disorder (BED), you might be wondering whether you can access treatment through telehealth—especially if finding time for in-person appointments feels overwhelming or if specialized eating disorder care isn’t available nearby. The good news: yes, you can legally receive medication for BED via telehealth in every U.S. state, and the regulatory landscape in 2026 makes it easier than ever.
This comprehensive guide will walk you through everything you need to know about getting BED treatment online, from which medications are available to state-specific rules, safety considerations, and what to expect from a quality telehealth provider.
Before diving into telehealth access, let’s clarify what BED is and why medication might be part of your treatment plan.
Binge Eating Disorder is characterized by recurrent episodes of eating large amounts of food within a discrete period (typically two hours), accompanied by a sense of lack of control. To meet diagnostic criteria, these episodes must occur at least once weekly for three months and be associated with distress—but without the compensatory purging behaviors seen in bulimia nervosa.
While therapy (particularly Cognitive Behavioral Therapy) remains the gold-standard treatment, medications can play a valuable supporting role. The FDA has approved one medication specifically for BED—lisdexamfetamine (Vyvanse), a controlled stimulant. However, because of strict regulations around controlled substances via telehealth, most online providers focus on two effective off-label medications:
Both are non-controlled medications, which means they face far fewer telehealth restrictions than stimulants or opioids.
Here’s the most important thing to understand: Federal law does not require an in-person visit before prescribing non-controlled medications via telehealth.
The Ryan Haight Act of 2008 placed strict requirements on prescribing controlled substances (like ADHD medications or opioids) via telemedicine, typically requiring an initial in-person examination. However, these rules never applied to non-controlled medications like Topamax or Wellbutrin.
During the COVID-19 pandemic, even the controlled-substance rules were temporarily relaxed. As of January 2026, the DEA has extended these telehealth flexibilities for controlled medications through December 31, 2026, while permanent rules are being finalized. But for your BED medications—which aren’t controlled—there’s no waiting game. Telehealth prescribing has always been legal and remains fully accessible.
| Medication Type | Telehealth Status | In-Person Required? |
|---|---|---|
| Non-controlled (Topamax, Wellbutrin) | ✅ Fully allowed | No |
| Controlled substances | 🟡 Temporarily allowed (through 12/31/2026) | Not currently (waiver in effect) |
While federal law sets the baseline, individual states can add their own requirements. The good news? Most states have embraced telehealth permanently, especially for non-controlled medications.
The majority of states—including California, New York, Texas, Florida, Delaware, Michigan, Wisconsin, and South Carolina—do not require an in-person visit before or during treatment with medications like Topamax or Wellbutrin via telehealth.
California has been particularly progressive, explicitly allowing telehealth examinations (even asynchronous ones via questionnaires) to satisfy the ‘appropriate prior examination’ requirement, as long as the standard of care is met.
New York recently implemented rules requiring in-person visits for controlled substance prescriptions (effective May 2025), but these do not apply to non-controlled BED medications.
A handful of states require periodic in-person follow-ups for ongoing telehealth care:
Even in these states, you can start treatment entirely online—the periodic visit requirement only kicks in after you’ve been in care for several months.
Regardless of your state’s specific rules, your telehealth provider must be licensed in the state where you’re located at the time of treatment. This is non-negotiable. Legitimate telehealth platforms verify your location at the start of each visit and ensure you’re matched with an appropriately licensed provider.
Multiple types of licensed healthcare providers can prescribe Topamax and Wellbutrin for BED through telehealth platforms:
Physicians can prescribe these medications in all states without restrictions (beyond being licensed in your state).
The landscape for NPs has evolved dramatically. As of 2025, 34 states plus Washington, D.C. grant Nurse Practitioners Full Practice Authority, meaning they can evaluate, diagnose, and prescribe independently without physician oversight.
Recent additions to this list include:
In states like California, New York, New Hampshire, and these newer FPA states, an NP can provide your entire BED treatment independently via telehealth.
In other states—including Texas, Florida, Georgia, and Alabama—NPs must work under a collaborative agreement with a physician. This doesn’t usually affect your patient experience (you’ll still primarily see the NP), but there’s a supervising physician in the background, and both names might appear on your prescription.
PAs can also prescribe these medications in all states, though they typically work under physician supervision regardless of location. The level of autonomy varies by state, but for non-controlled medications like those used for BED, PAs at reputable telehealth services can absolutely manage your care.
A legitimate telehealth evaluation for BED should be thorough—not a quick questionnaire leading to an automatic prescription.
Your first appointment will likely last 30-45 minutes and cover:
The provider will verify you meet DSM-5 diagnostic criteria for BED, which include:
You’ll sign a telehealth consent form that outlines:
Many providers will also use standardized assessments like the Eating Disorder Examination Questionnaire (EDE-Q) or Binge Eating Scale (BES) to objectively document symptom severity.
Don’t be surprised when the provider verifies your identity and location at the start of the visit. This isn’t intrusive—it’s a legal requirement in many states to ensure the provider is licensed where you’re located and to prevent fraud.
Let’s take a closer look at the two primary non-controlled medications prescribed via telehealth for Binge Eating Disorder.
How it works: Originally an anti-seizure medication, topiramate appears to reduce binge eating through effects on neurotransmitters involved in impulse control and reward pathways.
Dosing: Typically started at a low dose (25mg) and gradually increased over weeks to 50-200mg daily, taken in divided doses. The gradual titration helps minimize side effects.
Benefits:
Potential side effects:
Critical safety considerations:
Telehealth suitability: ✅ Excellent—fully legal in all states, can be prescribed with up to 90-day supplies and refills
How it works: This antidepressant affects dopamine and norepinephrine, potentially reducing the reward-driven aspects of binge eating while also treating co-occurring depression.
Dosing: Usually started at 150mg once or twice daily (sustained-release formulation), sometimes increased to 300mg daily. The XL (extended-release) formulation is often preferred for once-daily dosing.
Benefits:
Potential side effects:
Critical safety considerations:
Telehealth suitability: ✅ Excellent—non-controlled, widely prescribed via telehealth, refills available
| Feature | Topiramate (Topamax) | Bupropion (Wellbutrin) |
|---|---|---|
| DEA Schedule | None (non-controlled) | None (non-controlled) |
| FDA Approval for BED | No (off-label use) | No (off-label use) |
| Research Support | Moderate-strong | Moderate |
| Weight Effect | Often modest loss | Neutral to mild loss |
| Main Concern | Cognitive side effects, pregnancy risk | Seizure risk, contraindication in bulimia |
| Typical Prescription | 90-day supply with refills | 90-day supply with refills |
| Monitoring Needs | Metabolic panel, pregnancy test, cognitive function | Blood pressure, mood/suicide risk |
| Best For | Patients wanting weight loss help, no pregnancy plans | Patients with co-occurring depression, no seizure/purging history |
While telehealth expands access, it’s not appropriate for everyone. Responsible providers will screen you out if:
A reputable telehealth provider will recognize these limitations and refer you to appropriate in-person care rather than forcing a square peg into a round hole.
One advantage of non-controlled BED medications is the flexibility around refills.
Most states require prescribers to check the state PDMP database before prescribing controlled substances. Because Topamax and Wellbutrin are not controlled, PDMP checks are not legally mandated for these medications in most states.
However, quality telehealth providers may still review your prescription history as part of good clinical practice—for example, to ensure you’re not inadvertently taking another medication containing bupropion (which comes in many brand names) or to check for drug interactions.
Providers can typically prescribe:
However, expect regular follow-up appointments, especially when starting treatment:
Some states with periodic in-person requirements (Alabama, Georgia, New Hampshire) will expect at least annual in-person follow-up if you continue treatment long-term, though this can often be satisfied by seeing any local provider rather than traveling to a specific specialist.
The telehealth boom brought increased scrutiny—and unfortunately, some bad actors. Here’s how to identify legitimate, safe telehealth BED treatment:
🚩 Guaranteed prescriptions before evaluation: Legitimate providers don’t promise medications before assessing you
🚩 Minimal questions: If you’re only asked 3-5 questions before getting a prescription, that’s not adequate evaluation
🚩 No discussion of therapy: BED treatment should be multimodal. Providers who skip over mentioning therapy, nutrition counseling, or support groups may be overly focused on just prescribing
🚩 Selling medication directly: Your prescription should go to a regular pharmacy (or legitimate mail-order pharmacy), not come from the telehealth company’s warehouse
🚩 No licensed provider visible: You should see and interact with your actual prescriber, not just ‘clinical staff’
🚩 Pressure to start immediately: Good providers give you time to think, ask questions, and make an informed decision
✅ Comprehensive intake: 30+ minute initial evaluation covering detailed medical, psychiatric, and eating history
✅ Informed consent process: Clear explanation of off-label use, potential side effects, and alternatives
✅ Coordination with other providers: Willingness to communicate with your therapist, primary care doctor, or other specialists
✅ Structured follow-up plan: Scheduled appointments for monitoring, not just ‘message us if you have problems’
✅ Referral when appropriate: Recognition of their limitations and willingness to refer you elsewhere if needed
✅ Transparent pricing: Clear upfront costs, whether insurance is accepted, and what happens if medication isn’t appropriate
✅ Prescription to regular pharmacy: Uses standard e-prescribing to your chosen pharmacy
✅ Crisis resources: Provides clear guidance on what to do in emergencies or after-hours concerns
You may have heard about the ADHD telehealth company whose executives were indicted in 2024 for inappropriately prescribing controlled stimulants (Adderall) without adequate evaluation. This was a serious breach of standards—but it’s important to note this involved controlled substances, not the non-controlled medications used for BED.
The incident has actually led to improvements across the telehealth industry:
For BED treatment with non-controlled medications, the regulatory environment is actually less complex and the risk of predatory practices lower (since there’s less potential for abuse or diversion).
At Klarity Health, we’ve built our BED treatment program around the principles of accessible, evidence-based, safe care.
Comprehensive evaluation: Every patient receives a thorough 30-45 minute initial assessment with a licensed provider (MD, DO, or NP depending on your state).
Multimodal perspective: While we can prescribe medications when appropriate, we always discuss the role of therapy, nutrition counseling, and other supports. We’ll help you find therapists who specialize in eating disorders if you don’t already have one.
Informed decision-making: We explain that Topamax and Wellbutrin are used off-label for BED, walk through the evidence, discuss potential side effects, and ensure you’re making an informed choice.
Structured monitoring: Regular follow-ups to track symptom improvement, monitor for side effects, and adjust treatment as needed.
Provider availability: We maintain a network of licensed providers across all 50 states, so you’re not waiting weeks for an appointment
Transparent pricing: Clear upfront costs with no hidden fees. We accept both insurance and cash pay options, and we’ll help you understand what your insurance covers
Flexible scheduling: Evening and weekend appointments available to work around your life
Pharmacy freedom: Send prescriptions to any pharmacy you choose, including mail-order if that’s your preference
We recognize telehealth’s limitations. If during evaluation we determine you need:
…we’ll help connect you with appropriate in-person resources rather than forcing telehealth to fit.
Good news: Most insurance plans now cover telehealth visits at the same rate as in-person visits, a change made permanent in many states following the pandemic.
What’s typically covered:
Potential coverage limitations:
For those without insurance or with plans that don’t cover telehealth well, cash-pay pricing is typically:
At Klarity Health, we offer transparent cash pricing and will help you explore both insurance and cash-pay options to find what works for your budget.
The regulatory landscape continues to evolve, generally in the direction of expanded access while maintaining safety standards.
DEA final rule on telehealth: Expected by end of 2026, this will establish permanent regulations for controlled substance prescribing via telemedicine. While this doesn’t directly affect your non-controlled BED medications, it will clarify rules for providers who might also treat ADHD or other conditions requiring controlled substances.
More state practice authority expansions: Several additional states are considering bills to grant NPs full practice authority, which would expand the provider pool for telehealth services.
Integration of remote monitoring: Future BED treatment might incorporate wearable devices, food logging apps, and other digital tools that integrate with telehealth care.
Insurance coverage stabilization: As temporary pandemic-era coverage policies are made permanent (or expire), we’ll see clearer, more stable insurance coverage for telehealth mental health and eating disorder care.
The fundamental ability to prescribe non-controlled medications like Topamax and Wellbutrin via telehealth is here to stay. This was never dependent on pandemic waivers and is now firmly established as standard practice.
If you’re ready to explore telehealth treatment for Binge Eating Disorder, here’s how to begin:
Before your first appointment, prepare:
Look for platforms that:
Klarity Health checks all these boxes, with licensed providers across all 50 states, transparent pricing, both insurance and cash-pay options, and a commitment to comprehensive, evidence-based BED care.
Most telehealth platforms offer appointments within days (not weeks or months like traditional psychiatry). You’ll typically:
Remember: medication is a tool, not a cure. The most effective BED treatment combines:
Your telehealth provider can prescribe medication and provide medication management, but they’ll likely encourage you to work with a therapist and perhaps a dietitian as well.
Binge Eating Disorder is a serious but treatable condition. For too long, people struggled to access specialized care due to geography, scheduling constraints, cost, or stigma. Telehealth has transformed that landscape.
In 2026, you can legally and safely access BED medication treatment via telehealth from the comfort of your home, with licensed providers who can prescribe effective medications like topiramate and bupropion. The regulatory framework now supports this access with clear rules that balance patient safety with convenience.
Whether you’re just starting to acknowledge your binge eating, you’ve tried therapy and want to add medication, or you’re looking for a more convenient way to manage ongoing treatment, telehealth offers a viable path forward.
At Klarity Health, we’re committed to making that path as smooth and supportive as possible—with experienced providers, transparent pricing, flexible scheduling, and a genuine commitment to your recovery.
Ready to take the next step? Schedule an evaluation with Klarity Health today. Our licensed providers are available across all 50 states, we accept insurance and offer cash-pay options, and we’ll work with you to create a personalized treatment plan that fits your needs and your life.
You don’t have to struggle with binge eating alone—and you don’t have to wait weeks or travel hours to get help. Quality BED care is now just a video call away.
Verified as of: January 4, 2026
This article is based on the most current federal regulations and state laws governing telehealth prescribing practices. Key regulatory updates include:
DEA telemedicine extension: COVID-19 telehealth prescribing flexibilities for controlled substances remain in effect through December 31, 2026 (fourth extension). No federal in-person requirement has ever existed for non-controlled medications.
State verification: Information on state-specific rules reflects 2025 legislative sessions and late-2025 regulatory updates for priority states including Alabama, California, Delaware, Florida, Georgia, New Hampshire, New York, Texas, Michigan, and Wisconsin.
Source recency: Over 80% of sources cited are from 2025 or have been updated/verified in 2025. Older sources (2024) were used only when cross-referenced with newer information to confirm continued accuracy.
HHS Press Release (January 2026): ‘DEA Extends Telemedicine Prescribing Flexibilities Through December 31, 2026’ – Official announcement of the fourth extension of pandemic-era controlled substance telehealth rules. www.hhs.gov
Sheppard Mullin Health Law Blog (August 2025): ‘Telehealth and In-Person Visits: Tracking Federal and State Updates to Pandemic-Era Telehealth Exceptions’ – Comprehensive legal analysis of state-by-state telehealth prescribing requirements with statutory citations. www.sheppardhealthlaw.com
Center for Connected Health Policy (November-December 2025): State telehealth law database with detailed summaries of online prescribing requirements, in-person visit rules, and PDMP requirements by state. www.cchpca.org
Health Jobs Nationwide Blog (2025): ‘State-by-State Guide to Expanding Roles for PAs and NPs’ – Updated analysis of nurse practitioner practice authority changes including 2025 legislative updates. blog.healthjobsnationwide.com
DailyMed (NIH/FDA): FDA-approved prescribing information and black box warnings for bupropion hydrochloride, including contraindications for eating disorders and seizure risks. dailymed.nlm.nih.gov
Note: Alabama and South Carolina NP scope-of-practice changes were discussed in 2025 legislation but final implementation status remains pending verification. Federal DEA permanent telehealth rules expected by end of 2026; temporary state COVID-19 waivers should be monitored for extension or expiration beyond 2025.
Find the right provider for your needs — select your state to find expert care near you.